)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Fleury
Fleury (FLRY3) investor relations material
Fleury Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary6 Nov, 2026
Executive summary
Q3 gross revenue was R$2,695.5m, up 13.3% YoY and 9.9% organically; EBITDA rose 12.2% to R$672.2m and net income rose 42.9% to R$264.3m.
ROIC reached 18.7%, up 470 bps since 2Q23; Q3 operating cash flow was R$798.5m, up 11.1%.
Financial highlights
Q3 gross profit rose 16.6% to R$718.1m; gross margin expanded 79 bps to 28.9%.
9M gross revenue reached R$7,620.3m, up 12.6%; EBITDA rose 12.6% to R$1,891.1m, with a 26.9% margin.
9M net income was R$687.4m, up 33.1%.
Operating expenses were R$276.3m in Q3, up 10.8%, and equaled 11.1% of net revenue; 9M expenses rose 11.2% to R$788.9m.
Operating cash flow was R$798.5m in Q3 and R$1,758.9m in 9M, up 15.1% for the nine-month period.
Outlook and guidance
Management expects growth to remain primarily organic, citing ~10% organic growth year to date; efficiency gains and acquisition synergies remain priorities, without formal guidance.
Q4 activity tracked expectations amid holiday seasonality and scheduled unit retrofits; CapEx as a share of revenue is expected below prior years, with no full-year figure provided.
Tax-reform preparations cover billing, systems, controls and pricing for the transition starting January 2027; no material accounting impacts had been identified.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Fleury
- Revenue up 14.4%, EBITDA up 15.2%, and net income up 45.7% year-over-year.FLRY3
Q2 2026 - Revenue up 10.1%, EBITDA up 10.7%, net income up 12.2%, led by B2C and regional growth.FLRY3Q1 2026
- Double-digit revenue and EBITDA growth in 4Q25, led by B2C and strategic acquisitions.FLRY3Q4 2025
- Revenue up 11.5%, EBITDA stable, strong B2C growth, and robust cash generation.FLRY3Q3 2025
- Revenue up 2.8% with stable EBITDA margin; net income fell on higher costs and depreciation.FLRY3Q2 2025
- Gross revenue and net income rose, led by B2B, mobile, and successful integration efforts.FLRY3Q3 2024
- Net income up 47.5% and EBITDA margin expands to 26.4% on strong B2C and B2B growth.FLRY3Q2 2024
- Revenue and net profit rose over 6%, with strong digital and regional growth, and low leverage.FLRY3Q1 2025
- Revenue up 19.5%, EBITDA up 19.6%, net income up 32%, with strong cash flow and ESG results.FLRY3Q4 2024
Next Fleury earnings date
Investor Day 20264 Dec, 2026
Fleury
Next Fleury earnings date
Investor Day 20264 Dec, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Fleury S.A., provides medical services in the diagnostic, treatment, and clinical analysis, health management, and medical care areas in Brazil. It operates through the following segments: Hospital Fleury Pompéia, Hospital Fleury Ribeirão Preto, Hospital Fleury Júlio Mesquita, Hospital Fleury Campinas/Guarulhos Airport/São Paulo International Business Center, Hospital Fleury Guarulhos, Hospital Fleury São Bernardo do Campo. Fleury S.A also operates Diagnostic and Interventions Centers in 14 cities of Brazil and one center located in Moscow.